. 2015 Jun 23;36(12):9277–9283. doi: 10.1007/s13277-015-3656-z

Table 2.

Relationship between the expression levels of VEGF, HER-2, and EGFR mRNA in ESCC and clinicopathological features

Clinical data		n	VEGF ( $\bar{x} \pm s$ )	t/F	P	HER-2 ( $\bar{x} \pm s$ )	t/F	P	EGFR ( $\bar{x} \pm s$ )	t/F	P
Gender	Male	42	1.04 ± 0.09	−0.472	0.639	0.92 ± 0.06	−0.711	0.480	0.94 ± 0.95	−0.833	0.410
Gender	Female	18	1.05 ± 0.07	−0.472	0.639	0.94 ± 0.05	−0.711	0.480	1.37 ± 2.34	−0.833	0.410
Age	>60	23	1.03 ± 0.09	−1.609	0.113	0.94 ± 0.07	0.509	0.613	1.03 ± 1.06	−0.186	0.853
Age	≤60	37	1.07 ± 0.07	−1.609	0.113	0.93 ± 0.04	0.509	0.613	1.12 ± 1.91	−0.186	0.853
Ethnic groups	Han	20	1.08 ± 0.06	3.848*	0.027	0.99 ± 0.10	3.209*	0.048	1.50 ± 2.03	1.890*	0.067
	Uyghur	20	1.03 ± 0.06			0.92 ± 0.07			0.64 ± 0.09
	Kazakh	20	1.05 ± 0.05			0.93 ± 0.06			1.25 ± 0.67
Pathological grade	I	13	1.09 ± 0.07	2.029*	0.141	0.99 ± 0.11	2.521*	0.039	0.63 ± 0.07	1.832*	0.174
	II	20	1.03 ± 0.12			0.96 ± 0.07			1.69 ± 2.48
	III	27	1.04 ± 0.06			0.94 ± 0.01			0.89 ± 0.57
Clinical stage	II	16	0.93 ± 0.07	1.735*	0.186	1.06 ± 0.37	0.263*	0.770	0.71 ± 0.35	2.617*	0.652
	III	17	0.95 ± 0.09			1.33 ± 0.45			1.20 ± 2.10
	IV	27	0.98 ± 0.07			1.22 ± 0.59			0.99 ± 0.97
Lymph node metastasis	有	33	1.05 ± 0.10	2.027	0.047	1.02 ± 0.08	2.383	0.020	0.97 ± 0.04	2.198	0.031
Lymph node metastasis	无	27	1.00 ± 0.07	2.027	0.047	0.97 ± 0.08	2.383	0.020	0.93 ± 0.06	2.198	0.031

*F value